211 results
Page 5 of 11
10-KT
EX-31.2
a3fw7z
31 Mar 21
Annual report (with FYE transition)
4:33pm
10-KT
ccgbq3
31 Mar 21
Annual report (with FYE transition)
4:33pm
10-KT
EX-31.1
5hzgo 5dg7
31 Mar 21
Annual report (with FYE transition)
4:33pm
8-K
EX-10.3
629j mq9x
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
8-K
EX-10.1
ru6mph8
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
8-K
EX-10.2
v9l404i
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
8-K
EX-10.4
ww749s
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
8-K
EX-10.5
l9wcnd6
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
424B5
r6fgs0qwgwk9
18 Dec 20
Prospectus supplement for primary offering
1:26pm
424B5
hylon9tqjh 20z0x0x
2 Oct 20
Prospectus supplement for primary offering
4:24pm
8-K
EX-10.4
nj1jw4 ulpi4t60mwht
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm